MassDevice6h
Mass layoffs start at HHS: ‘FDA as we’ve known it is finished’
"The ongoing gutting of the FDA is likely to cause American deaths," said the CEO of one medical device developer.
BioSpace9h
FDA Layoffs Continue as Former Commissioner Robert Califf Speaks Out
The latest cuts, which are part of a larger reduction of 10,000 at the Department of Health and Human Services, were ...
Fierce Pharma1d
As FDA's Peter Marks resigns, industry watchers size up vaccine, cell and gene therapy hits
As the FDA wavers from cuts, changes and departures under the second Trump administration, another vital figure of the agency ...
BioSpace1d
Marks’ Sudden Departure From FDA Magnifies Uncertainty, Sends Biopharma Shares Down
The stock market—and biotech insiders—reacted negatively to the allegedly forced resignation of CBER Director Peter Marks, ...
GEN - Genetic Engineering and Biotechnology News1d
Industry Voices Alarm as Peter Marks Departs FDA
The sudden departure of Peter Marks, MD, from the FDA has prompted a chorus of criticism and despair from industry leaders and trade organizations.
JD Supra5d
FDA Publishes Case Studies and User Guide for Rare Disease Drug Developers
Drug development programs face unique challenges in demonstrating the safety and effectiveness of drugs for treating rare diseases. The ...
Explore more
Fierce Pharma6d
Senate confirms Johns Hopkins surgeon Marty Makary to lead FDA amid turbulence at the agency
Despite the uncertainty currently sweeping through the Food and Drug Administration, President Donald Trump’s pick to lead ...